Literature DB >> 22290307

Predictive index for the onset of medication overuse headache in migraine patients.

T Onaya1, M Ishii, H Katoh, S Shimizu, H Kasai, M Kawamura, Y Kiuchi.   

Abstract

Migraine patients are particularly prone to develop medication overuse headache (MOH). However, the risk factors for the transformation of migraine to MOH are still not clear. We investigated gene polymorphisms, personality traits, and characteristics of headache and lifestyle in 47 migraine patients (aged 36.4 ± 10.3) and 22 MOH patients (aged 39.6 ± 9.9) who progressed from migraine and made a scoring system for a predictive index (PI) of the onset of MOH in patients with migraine. By multivariate logistic stepwise regression analysis, type of migraine, regular and sufficient dietary intake, and methylenetetrahydrofolate reductase (MTHFR) C677T (rs1801133) and dopamine D2 receptor (DRD2) C939T (rs6275) polymorphisms were selected as significant factors that contribute independently to the development from migraine to MOH (P < 0.05). The regression coefficients (β) of these four selected factors were approximated and scored. The PI score in MOH patients (7.32 ± 1.60) was significantly higher than that in migraine patients (4.62 ± 1.83, P < 0.001). The proposed scoring system should in the future be the object of larger studies to confirm its validity.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 22290307     DOI： 10.1007/s10072-012-0955-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  43 in total

1.  Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder.

Authors:  J Deckert; M Catalano; Y V Syagailo; M Bosi; O Okladnova; D Di Bella; M M Nöthen; P Maffei; P Franke; J Fritze; W Maier; P Propping; H Beckmann; L Bellodi; K P Lesch
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

2.  Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period.

Authors:  Chelsea A Meskunas; Stewart J Tepper; Alan M Rapoport; Fred D Sheftell; Marcelo E Bigal
Journal:  Headache       Date:  2006-05       Impact factor: 5.887

3.  5-HT1B receptor polymorphism and clinical response to sumatriptan.

Authors:  A MaassenVanDenBrink; M N Vergouwe; R A Ophoff; P R Saxena; M D Ferrari; R R Frants
Journal:  Headache       Date:  1998-04       Impact factor: 5.887

4.  Serotonergic activity contributes to analgesic overuse in chronic tension-type headache.

Authors:  Jeong Wook Park; Joong Seok Kim; Young In Kim; Kwang Soo Lee
Journal:  Headache       Date:  2005-10       Impact factor: 5.887

5.  5HT in migraine patients with medication-induced headache.

Authors:  R Hering; V Glover; K Pattichis; T Catarci; T J Steiner
Journal:  Cephalalgia       Date:  1993-12       Impact factor: 6.292

6.  Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage.

Authors:  B C Blount; M M Mack; C M Wehr; J T MacGregor; R A Hiatt; G Wang; S N Wickramasinghe; R B Everson; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

7.  Effect of the methylenetetrahydrofolate reductase 677C-->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample.

Authors:  Angelika de Bree; W M Monique Verschuren; Anne-Lise Bjørke-Monsen; Nathalie M J van der Put; Sandra G Heil; Frans J M Trijbels; Henk J Blom
Journal:  Am J Clin Nutr       Date:  2003-03       Impact factor: 7.045

8.  Lack of association between five serotonin metabolism-related genes and medication overuse headache.

Authors:  Sabina Cevoli; Nadia Marzocchi; Sabina Capellari; Chiara Scapoli; Giulia Pierangeli; Daniela Grimaldi; Federica Naldi; L Alberto Pini; Pasquale Montagna; Pietro Cortelli
Journal:  J Headache Pain       Date:  2010-02       Impact factor: 7.277

9.  PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1).

Authors:  B Rigat; C Hubert; P Corvol; F Soubrier
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

10.  Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor.

Authors:  G Sarkar; S Kapelner; D K Grandy; M Marchionni; O Civelli; J Sobell; L Heston; S S Sommer
Journal:  Genomics       Date:  1991-09       Impact factor: 5.736
View more
  5 in total

Review 1.  Medication overuse headache.

Authors:  Valerie Cheung; Farnaz Amoozegar; Esma Dilli
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

2.  Clinical Response to Valproate in Patients with Migraine.

Authors:  Mizuki Ichikawa; Hirotaka Katoh; Tatsuya Kurihara; Masakazu Ishii
Journal:  J Clin Neurol       Date:  2016-10       Impact factor: 3.077

3.  The role of personality, disability and physical activity in the development of medication-overuse headache: a prospective observational study.

Authors:  Louise S Mose; Susanne S Pedersen; Birgit Debrabant; Rigmor H Jensen; Bibi Gram
Journal:  J Headache Pain       Date:  2018-05-25       Impact factor: 7.277

4.  Association of expression of DRD2 rs1800497 polymorphism with migraine risk in Han Chinese individuals.

Authors:  Yingfeng Deng; Jianping Huang; Huijun Zhang; Xueqin Zhu; Qin Gong
Journal:  J Pain Res       Date:  2018-04-12       Impact factor: 3.133

5.  Development of an AmpliSeqTM Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain.

Authors:  Dario Kringel; Mari A Kaunisto; Catharina Lippmann; Eija Kalso; Jörn Lötsch
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.